BLINCYTO 35 mcg
- Name: BLINCYTO
- Generic Name: Blinatumomab
- Strength: 35 mcg Single-Dose Vial
- Manufactured : Amgen Inc
- B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1%.
- Relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
- Assess patients with blinatumomab injection for signs and symptoms of neurological toxicities. Advise outpatients on blinatumomab to contact their health specialist if they develop signs/symptoms of neurological toxicities.
- Monitor patients with blincyto doses for signs and symptoms of infection and treat appropriately.
- Assess laboratory parameters (including, but not limited to, WBC count and absolute neutrophil count) during blinatumomab infusion. Interrupt this medication if prolonged neutropenia occurs.
- Monitor aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), and total blood bilirubin before the start of and while on blincyto 35 mcg treatment.
- Assess patients who develop signs of pancreatitis. Management of pancreatitis may need either temporary interruption or discontinuation of blincyto injection and dexamethasone.
- Vaccination with live virus vaccines is not recommended for at least 2 weeks prior to the start of blinatumomab 35 mcg treatment, during treatment, and until immune recovery following the last cycle of blinatumomab.
What documents are required to import BLINCYTO to India?
BLINCYTO (Blinatumomab 35 mcg) can be imported by patients or government hospitals on the name of the patients only.
The following documentation required to import the product:
- Valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients id proof (issued by government of India)
How does order be confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription of Doctor
- Import permit if applicable
Is BLINCYTO available in India?
BLINCYTO is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
BLINCYTO can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
IPN (Indian Pharma Network) can facilitate the supply of BLINCYTO (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-9650877511 | Toll-Free No: 1800-889-1064 or write us at info@indianpharmanetwork.in for blinatumomab price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source the BLINCYTO (Cancer Treatment Medicines) from across the globe, and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Blincyto® ?
Blinatumomab is Generic Name for the trade name drug Blincyto®.
What is the Manufacturer Name of Blincyto®?
Blincyto® is manufactured by Amgen, Inc.
Is Blincyto® approved by the FDA?
Yes, Blincyto® is approved by the FDA. Date of approval: 2014.
What is the dosage and form of Blincyto® available?
Blincyto® is available as 35 mcg of lyophilized powder in a single-use vial for reconstitution.
How much does Blincyto® cost in India?
You can call or WhatsApp +91-9650877511 or send mail to info@indianpharmanetwork.in to know the blincyto cost.
What are the Highlights of prescribing information for Blincyto®?
Click Here to download full Blinatumomab prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis. CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis.